13F-HR filed by Atle Fund Management AB
Atle Fund Management AB filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 38 holding rows worth $164,003,810.
- Accession
- 0001381843-24-000006
- Filer
- CIK 1381843
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 38 entries on the cover page, a total value of $164,003,810 stated on the cover page (in dollars after the unit check, H1), rows summing to $164,003,810 with VALUE read as dollars as filed, 13F file number 028-12171. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 532457108 | COM | 27,144 | $24,575,634 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 31,680 | $16,133,356 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 112,734 | $13,956,469 | dollars as filed | |
| Thermo Fisher Scientific Inc. | 883556102 | COM | 19,458 | $10,760,274 | dollars as filed | |
| Amgen Inc. | 031162100 | COM | 27,589 | $8,620,183 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 106,557 | $8,205,954 | dollars as filed | |
| REGENERON PHARMACEUTICALS COM | 75886F107 | Stock | 6,893 | $7,244,749 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 15,095 | $7,075,328 | dollars as filed | |
| CENCORA INC COM | 03073E105 | Stock | 30,320 | $6,831,096 | dollars as filed | |
| Stryker Corporation | 863667101 | COM | 19,983 | $6,799,215 | dollars as filed | |
| AbbVie,Inc. | 00287Y109 | COM | 35,618 | $6,109,199 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 34,483 | $3,909,682 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 36,505 | $3,371,966 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 23,630 | $3,253,142 | dollars as filed | |
| IQVIA HLDGS INC COM | 46266C105 | Stock | 13,984 | $2,956,776 | dollars as filed | |
| MOLINA HEALTHCARE INC | 60855R100 | COM | 9,500 | $2,824,350 | dollars as filed | |
| CARDINAL HEALTH INC | 14149Y108 | COM | 27,500 | $2,703,800 | dollars as filed | |
| UFP TECHNOLOGIES INC | 902673102 | COM | 9,800 | $2,585,926 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 75,200 | $2,571,088 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 35,841 | $2,454,750 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 40,691 | $1,939,333 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 30,837 | $1,824,625 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 39,100 | $1,769,275 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 68,800 | $1,658,080 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 54,395 | $1,506,741 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 148,207 | $1,470,213 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 75,794 | $1,456,002 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 7,624 | $1,400,071 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 53,432 | $1,353,432 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 22,496 | $1,241,554 | dollars as filed | |
| HARMONY BIOSCIENCES HLDGS IN | 413197104 | COM | 34,900 | $1,052,933 | dollars as filed | |
| IMMUNOCORE HLDGS PLC ADS | 45258D105 | ADR | 23,778 | $805,836 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 226,145 | $786,984 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 20,199 | $688,179 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 34,328 | $645,366 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 143,407 | $609,479 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 64,321 | $481,121 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 184,900 | $371,649 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001381843-24-000006 | this filing | 2024-08-14 | acceptance time not in the bulk data set |